4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Outlook Therapeutics, Inc. (OTLK) operates in the Biotechnology industry and is headquartered in Iselin, United States with about 17 employees. Its market capitalization is roughly $203 million. In the fiscal year ended 2025-09-30, OTLK reported $1M in revenue and ($62M) in net income.
Outlook Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for ophthalmic indications.
Interactive charts & full statements → Open the OTLK valuation workbench →
| Income statement | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Total Revenue | $1M | $0M | $0M | $0M | — |
| Gross Profit | $0M | $0M | — | — | — |
| Operating Income (EBIT) | ($67M) | ($72M) | ($53M) | ($63M) | — |
| Net Income | ($62M) | ($75M) | ($59M) | ($66M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | ($1M) | ($0M) | $2M | $0M | — |
| Gross Profit | $0M | ($1M) | ($1M) | $1M | $0M | — |
| Operating Income (EBIT) | ($14M) | ($14M) | ($17M) | ($16M) | ($12M) | — |
| Net Income | ($4M) | ($23M) | ($13M) | ($20M) | ($46M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Total Assets | $19M | $29M | $32M | $28M | — |
| Total Liabilities | $51M | $102M | $47M | $20M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive OTLK viewer.
About TickerBase · Data methodology & sources